Anemia as a risk factor for tuberculosis: a systematic review and meta-analysis

Environmental Health and Preventive Medicine

Volumn 26, Issue 1, 2021, Pages

  Gelaw, Yemataw ^a   Getaneh, Zegeye ^a   Melku, Mulugeta ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

and Meta analysis; Anemia; Hazard ratio; Systematic review; Tuberculosis

Indexed keywords

HEMOGLOBIN;

ADAPTIVE IMMUNITY; ADULT; ANEMIA; ARTICLE; CAMEROON; CELL PROLIFERATION; COCHRANE LIBRARY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMBASE; HUMAN; INCIDENCE; MEDICAL SUBJECT HEADINGS; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PREVALENCE; PUBLICATION BIAS; RISK FACTOR; SYSTEMATIC REVIEW; TUBERCULOSIS;

ANEMIA; HUMANS; RISK FACTORS; TUBERCULOSIS;

EID: 85099981554     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1186/s12199-020-00931-z     Document Type: Article

References (54)

1. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013;1(1):16–25. DOI: 10.1016/S2214-109X(13)70001-9
2. WHO, Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity; World Health Organization; Available from: https://www.who.int/vmnis/indicators/haemoglobin.pdf; Access date; October 20, 2020.
3. De Benoist B, Cogswell M, Egli I, McLean E. Worldwide prevalence of anaemia 1993-2005. WHO Global Database of anaemia: World Health Organization; 2008.
4. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;9(5):923–9. DOI: 10.1183/09031936.00137106
5. Barzegari S, Afshari M, Movahednia M, Moosazadeh M. Prevalence of anemia among patients with tuberculosis: a systematic review and meta-analysis. Indian J Tuberc. 2019;66(2):299–307. DOI: 10.1016/j.ijtb.2019.04.002
6. Nagu TJ, Spiegelman D, Hertzmark E, Aboud S, Makani J, Matee MI, et al. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PloS one. 2014;9(3).
7. Hella J, Cercamondi CI, Mhimbira F, Sasamalo M, Stoffel N, Zwahlen M, et al. Anemia in tuberculosis cases and household controls from Tanzania: contribution of disease, coinfections, and the role of hepcidin. PLoS One. 2018;13(4):e0195985. DOI: 10.1371/journal.pone.0195985
8. Bashir BA, Abdallah SA, Mohamedani AA. Anemia among patients with pulmonary tuberculosis in port Sudan, eastern Sudan. Int J Recent Sci Res. 2015;6(5):4128–31.
9. Oliveira MG, Delogo KN. Oliveira HMdMG, Ruffino-Netto A, Kritski AL, Oliveira MM. Anemia in hospitalized patients with pulmonary tuberculosis. J Bras Pneumol. 2014;40(4):403–10. DOI: 10.1590/S1806-37132014000400008
10. Beshir MT, Beyene AH, Tlaye KG, Demelew TM. Incidence and predictors of tuberculosis among HIV-positive children at Adama Referral Hospital and Medical College, Oromia, Ethiopia: a retrospective follow-up study. Epidemiol Health. 2019;41:1–8. DOI: 10.4178/epih.e2019028
11. Kerkhoff AD, Wood R, Vogt M, Lawn SD. Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. Journal of acquired immune deficiency syndromes (1999). 2014;66(1):33-40.
12. Erkurt MA, Aydogdu I, Dikilitaş M, Kuku I, Kaya E, Bayraktar N, et al. Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008;17(2):131–5. DOI: 10.1159/000112967
13. Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. The effect of iron deficiency anemia on the function of the immune system. Hematol J. 2005;5(7):579–83. DOI: 10.1038/sj.thj.6200574
14. Nagu TJ, Spiegelman D, Hertzmark E, Aboud S, Makani J, Matee MI, et al. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam. Tanzania PloS one. 2014;9(3):e91229. DOI: 10.1371/journal.pone.0091229
15. Devi U, Rao CM, Srivastava VK, Rath PK, Das BS. Effect of iron supplementation on mild to moderate anaemia in pulmonary tuberculosis. Br J Nutr. 2003;90(3):541–50. DOI: 10.1079/BJN2003936
16. Umakanth M. Anemia among tuberculosis patient in teaching hospital Batticaloa, Sri Lanka. Int J Med Heal Res. 2017;3(5):95–7.
17. Chu K-A, Hsu C-H, Lin M-C, Chu Y-H, Hung Y-M, Wei JC-C. Association of iron deficiency anemia with tuberculosis in Taiwan: a nationwide population-based study. PLoS One. 2019;14(8):e0221908. DOI: 10.1371/journal.pone.0221908
18. WHO, Systematic screening for active tuberculosis: principles and recommendations, World Health Organization, 2013, Available from https://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf, Access date November 30, 2019.
19. Gurvits GE, Lan G. Enterolithiasis. World J Gastroenterol. 2014;20(47):17819–29. DOI: 10.3748/wjg.v20.i47.17819
20. Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker LG, Lawn SD. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med. 2015;13(70):1–13.
21. Enju L, MAKUBI A, DRAIN P, SPIEGELMAN D, SANDO D, Nan L, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy in Tanzania. AIDS (London, England). 2015;29(11):1391-9.
22. Alemu YM, Andargie G, Gebeye E. High incidence of tuberculosis in the absence of isoniazid and cotrimoxazole preventive therapy in children living with HIV in Northern Ethiopia: a retrospective follow-up study. PLoS One. 2016;11(4):e0152941. DOI: 10.1371/journal.pone.0152941
23. Phyo K, Oo M, Harries A, Saw S, Aung T, Moe J, et al. High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011–2017. Int J Tuberc Lung Dis. 2019;23(3):349–57. DOI: 10.5588/ijtld.18.0436
24. Iroezindu M, Ofondu E, Mbata G, Van Wyk B, Hausler H, Au D, et al. Factors associated with prevalent tuberculosis among patients receiving highly active antiretroviral therapy in a Nigerian tertiary hospital. Ann Med Health Sci Res. 2016;6(2):120–8. DOI: 10.4103/2141-9248.181837
25. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9. DOI: 10.1186/2046-4053-4-1
26. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute, 2017. Available from https://reviewersmanual.joannabriggs.org/: Access date December 25, 2019.
27. Lienhardt C, Fielding K, Sillah J, Bah B, Gustafson P, Warndorff D, et al. Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa. Int J Epidemiol. 2005;34(4):914–23. DOI: 10.1093/ije/dyi100
28. Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV. Ethiop J Health Sci. 2011;21(2):131–9.
29. Pefura Yone EW, Kengne AP, Moifo B, Kuaban C. Prevalence and determinants of extrapulmonary involvement in patients with pulmonary tuberculosis in a Sub-Saharan African country: a cross-sectional study. Scand J Infect Dis. 2013;45(2):104–11. DOI: 10.3109/00365548.2012.714905
30. Ayalaw SG, Alene KA, Adane AA. Incidence and predictors of tuberculosis among HIV positive children at University of Gondar Referral Hospital, northwest Ethiopia: a retrospective follow-up study. Int Scholarly Res Notices. 2015;2015:1–6. DOI: 10.1155/2015/307810
31. Batista JdAL, Maruza M, de Alencar Ximenes RA, Santos ML, Montarroyos UR, de Barros Miranda-Filho D, et al. Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PloS one. 2013;8(5):e63916.
32. McDermid JM, Hennig BJ, van der Sande M, Hill AV, Whittle HC, Jaye A, et al. Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infect Dis. 2013;13(48):1–9.
33. Li N, Manji KP, Spiegelman D, Muya A, Mwiru RS, Liu E, Chalamilla G, Fawzi WW, Duggan C. Incident tuberculosis and risk factors among HIV-infected children in Tanzania. AIDS. 2013;27(8):1273–81.
34. Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, et al. Tuberculosis incidence and risk factors among human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy in a large HIV program in Nigeria. Open Forum Infect Dis. 2015;2(4):1–11. DOI: 10.1093/ofid/ofv154
35. Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg. 2013;107(4):235–42. DOI: 10.1093/trstmh/trt001
36. Klote MM, Agodoa LY, Abbott KC. Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients. Nephrol Dialysis Transplantation. 2006;21(11):3287–92. DOI: 10.1093/ndt/gfl488
37. Karstaedt A, Bolhaar M. Tuberculosis in older adults in Soweto, South Africa. Int J Tuberc Lung Dis. 2014;18(10):1220–2. DOI: 10.5588/ijtld.14.0210
38. Shu C-C, Wu V-C, Yang F-J, Pan S-C, Lai T-S, Wang J-Y, et al. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis. PLoS One. 2012;7(8):e42592. DOI: 10.1371/journal.pone.0042592
39. Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol: WJG. 2009;15(37):4653–8. DOI: 10.3748/wjg.15.4653
40. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23. DOI: 10.1056/NEJMra041809
41. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study. J Am Coll Cardiol. 2002;40(1):27–33. DOI: 10.1016/S0735-1097(02)01938-1
42. WHO. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. World Health Organization, 2015. Available from: http://apps.who.int/iris/bitstream/handle/10665/43894/9789241596657_eng.pdf?ua=1: Access Date: November 1, 2018.
43. Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections. Gram-Positive Pathogens. 2019;7(4):GPP3 -0022-2018.
44. Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol. 2011;2011:814943. DOI: 10.1155/2011/814943
45. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001;19(1):93–129. DOI: 10.1146/annurev.immunol.19.1.93
46. Aly SS, Fayed HM, Ismail AM, Hakeem GLA. Assessment of peripheral blood lymphocyte subsets in children with iron deficiency anemia. BMC Pediatr. 2018;18(1):49. DOI: 10.1186/s12887-018-0990-5
47. Das I, Saha K, Mukhopadhyay D, Roy S, Raychaudhuri G, Chatterjee M, et al. Impact of iron deficiency anemia on cell-mediated and humoral immunity in children: A case control study. J Natural Sci Biol Med. 2014;5(1):158–63. DOI: 10.4103/0976-9668.127317
48. Cronjé L. N E, EK, L. B. Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions. FEMS Immunol Med Microbiol. 2005;1(45):103–12. DOI: 10.1016/j.femsim.2005.02.007
49. Cherayil BJ. Iron and immunity: immunological consequences of iron deficiency and overload. Arch Immunol Ther Exp (Warsz). 2010;58(6):407–15. DOI: 10.1007/s00005-010-0095-9
50. World Health Organization. Iron Deficiency Anaemia Assessment, Prevention and Control A guide for programme managers. World Health Organization; 2001. Availabel from: https://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf: Access date: October, 19, 2020.
51. Saeed F, Nadeem M, Ahmed RS, Tahir Nadeem M, Arshad MS, Ullah A. Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds–a review. Food Agricultural Immunol. 2016;27(2):205–29. DOI: 10.1080/09540105.2015.1079600
52. Buttari B, Profumo E, Riganò R. Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. Biomed Res Int. 2015;2015:616834. DOI: 10.1155/2015/616834
53. Bishlawy IE. Red blood cells, hemoglobin and the immune system. Med Hypotheses. 1999;53(4):345–6. DOI: 10.1054/mehy.1997.0778
54. Ibrahim B, Sani AM, Timothy B. Prevalence of glucose-6-phosphate dehydrogenase deficiency among children aged 0-5 years infected with Plasmodium falciparum in Katsina State, Nigeria. Adv Biochem. 2016;4(6):66–73.